Clinical Trial Update: IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures [Phase 4]

View source ↗

Summary

Phase 4 trial assessing intravenous levetiracetam (Keppra) in the emergency department to prevent early recurrent seizures after a tonic-clonic seizure; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tonic-clonic Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Emory University | Conditions: Tonic-clonic Seizure | Phase 4 | Status: COMPLETED | Results posted: 2013-08-05